Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MXCT is 91.78M, and currently, short sellers hold a 3.58% ratio of that float. The average trading volume of MXCT on May 08, 2024 was 550.35K shares.
MXCT) stock’s latest price update
The stock of MaxCyte Inc (NASDAQ: MXCT) has increased by 26.21 when compared to last closing price of 3.93.Despite this, the company has seen a gain of 31.22% in its stock price over the last five trading days. Zacks Investment Research reported 2024-05-07 that MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.11 per share a year ago.
MXCT’s Market Performance
MaxCyte Inc (MXCT) has seen a 31.22% rise in stock performance for the week, with a 19.52% gain in the past month and a 3.12% surge in the past quarter. The volatility ratio for the week is 5.56%, and the volatility levels for the past 30 days are at 4.31% for MXCT.. The simple moving average for the past 20 days is 28.38% for MXCT’s stock, with a 20.43% simple moving average for the past 200 days.
Analysts’ Opinion of MXCT
Many brokerage firms have already submitted their reports for MXCT stocks, with Craig Hallum repeating the rating for MXCT by listing it as a “Buy.” The predicted price for MXCT in the upcoming period, according to Craig Hallum is $7 based on the research report published on November 29, 2023 of the previous year 2023.
MXCT Trading at 20.66% from the 50-Day Moving Average
After a stumble in the market that brought MXCT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.55% of loss for the given period.
Volatility was left at 4.31%, however, over the last 30 days, the volatility rate increased by 5.56%, as shares surge +21.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.10% upper at present.
During the last 5 trading sessions, MXCT rose by +31.75%, which changed the moving average for the period of 200-days by +4.18% in comparison to the 20-day moving average, which settled at $3.91. In addition, MaxCyte Inc saw 5.53% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MXCT starting from Johnston John Joseph, who sale 5,000 shares at the price of $4.41 back on Mar 26 ’24. After this action, Johnston John Joseph now owns 120,583 shares of MaxCyte Inc, valued at $22,025 using the latest closing price.
Johnston John Joseph, the Director of MaxCyte Inc, sale 5,000 shares at $5.12 during a trade that took place back on Jan 26 ’24, which means that Johnston John Joseph is holding 120,583 shares at $25,585 based on the most recent closing price.
Stock Fundamentals for MXCT
Current profitability levels for the company are sitting at:
- -1.05 for the present operating margin
- 0.86 for the gross margin
The net margin for MaxCyte Inc stands at -0.83. The total capital return value is set at -0.19. Equity return is now at value -15.42, with -13.56 for asset returns.
Based on MaxCyte Inc (MXCT), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -1.5. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -20.17.
Currently, EBITDA for the company is -44.04 million with net debt to EBITDA at 0.09. When we switch over and look at the enterprise to sales, we see a ratio of 11.72. The receivables turnover for the company is 7.35for trailing twelve months and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.26.
Conclusion
To put it simply, MaxCyte Inc (MXCT) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
